VXRT:OTCMKTS
Vaxart Inc
$0.44
arrow_downward
-0.68%(-0.0030) 1 日
10月2日, 16:00:00 GMT-4 · USD
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoVXRT の上位の分析情報を生成しています...
始値
$0.45
高値
$0.46
安値
$0.43
時価総額
1.06億
平均出来高
27.03万
取引量
23.94万
株価収益率
2.68
52 週高値
$0.84
52 週安値
$0.30
EPS
$0.16
ベータ版
1.05
発行済株式数
2.43億
従業員数
65
始値
$0.45
高値
$0.46
安値
$0.43
時価総額
1.06億
平均出来高
27.03万
取引量
23.94万
株価収益率
2.68
52 週高値
$0.84
52 週安値
$0.30
EPS
$0.16
ベータ版
1.05
発行済株式数
2.43億
従業員数
65
ニュース記事
情報源: ウェブソース、ニュース パートナー
www.nnn.co.jp
·
6 時間前
ＮＹ株は続伸し２５０ドル高で終える
東奥日報社
·
6 時間前
ＮＹ株式 ２日終値 ｜全国のニュース｜Web東奥
BigGo ファイナンス
·
4 時間前
米雇用統計が予想外の弱さ、利上げ懸念が後退 ナスダックは週足で3週連続高
みんかぶ FX/為替
·
6 時間前
ダウ平均は続伸＝米国株概況
プロフィール
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in 2004, the company later changed its name to Vaxart, Inc. in July 2007, after reincorporating in Delaware. A significant development in the company's history was the reverse merger with Aviragen Therapeutics, Inc. on February 13, 2018, which led to Vaxart becoming a wholly owned subsidiary of Aviragen. Post-merger, the company continued as Vaxart, Inc.
Vaxart's development portfolio includes a range of oral vaccines targeting infectious diseases such as norovirus, COVID-19, and seasonal influenza, as well as therapeutic vaccines like those targeting HPV. Wikipedia
Vaxart Inc について